ELSEVIRE Global Medical News
Search Elsevier Global Medical News
Clinical Neurology News
 
 
  Diamond Headache   American Academy of Neurology   American Headache Society
 
This news site is not sanctioned by, nor part of, the Diamond Headache Foundation, The American Academy of Neurology OR The American Headache Society.
News covering selected sessions related to migraine from 2008 medical conferences.
Diamond Headache Clinic Research and Educational Foundation Annual Research Summit Scottsdale, Arizona February 18-22, 2008
 
 
  Gender Based issues in Epilepsy Management
 
  Migraine Preventative therapies
 
  Distinquising Between Migraine and Tension Headache
 
Perimenopuasl Issues and Migraine
 
  Migraine Headache-Diagnosis and Treatment
 
  Biology of Migraine and other Headaches
 
  Exertional Headache: Uncommon, Usually Benign,
but Worrisome
 
  Vertigo, Dizziness Often Reported With Migraine, but Are They Related?
 
  Central Sensitization and Cutaneous Allodynia Implication on Migraine Treatment
 
  Expect the Unexpected When Headache Occurs in Older Patients
 
  Often Implicated, the Eye Rarely Causes Headache
 
Defining the Complicated Migraine
 
Studies Reveal Migraine with Aura is a Risk Factor for Heart Disease
 
Hormonal Therapies for Migraine: Risks vs Benefits
 
Menstrual Migraines
 
Cluster Headache
 
Emergency Department Treatment of Headache
 
 
  Migraine Headache—Diagnosis and Treatment  
BY MAURY BREECHER
Contributing Writer
SCOTTSDALE, ARIZ. (ECCC)— The importance of diet to headache patients and how to avoid weekend headaches were just a few of the clinical insights shared by Dr. Seymour Diamond on February 18 during his opening address to more than 200 physicians at a Headache Research Summit presented by the Diamond Headache Clinic Research and Educational Foundation.
Dr. Diamond is the director and founder of the Headache Clinic and has a career that spans more than 50 years as a headache specialist.
He reported that because of the important role diet plays in headache patients whose pain is set off by exposure to ingestible items, such as aged cheese, chocolate, alcoholic beverages, and medicines, the Diamond Headache Clinic developed a menu plan that helps about 30% of all headache patients by eliminating those foods. He offered to send the menu plan/diet to any physician who requested.
Dr. Diamond then shared what physicians can do to help their patients remain headache-free on the weekends.
He explained that many headache patients have physiological causes for headache, such as keeping late hours, oversleeping, and skipping breakfast. There can also be psychological causes, such as anxiety, depression, fear, and repressed anger.
“To avoid weekend headaches, my instructions to patients are to get up the same time every day and to eat the same breakfast,” said Dr. Diamond. “If it is a weekend and they are still sleepy, they then can go back to bed. “If they do that, they will avoid a lot of weekend headaches.”
According to Dr. Diamond, headache patients often have warnings of approaching migraine that may include talkativeness, a feeling of well-being and surge of energy, hunger, drowsiness, depression, irritability, and tension.
He then traced the history of drug therapy for headache, making the point that the perfect headache drug has yet to be developed. Many classes of drugs have been tried with various degrees of satisfaction, he said, but even the triptans don’t work on every patient all the time.
Among the drugs that can provide some benefits to different subpopulations of patients, Dr. Diamond continued, are ergotamine with caffeine, aspirin, corticosteroids for prolonged migraines, ergotamine with NSAIDS, NSAIDs such as indomethacin, naproxen, ibuprofen, and ketoprofen. He added that other sometimes useful drugs include the ß-blockers, propranolol and timolol; the calcium channel blockers, verapamil and nimodipine; antiepileptic agents, such as phenytoin, the triptans; and tricyclics antidepressants.
Tricyclics are helpful to many migraine patients, continued Dr. Diamond.
“If tricyclics antidepressants, such as amitriptyline, doxepin, and protriptyline, went before the FDA today and we didn’t know they had anti-depressant benefits, they would be approved as painkillers,” said Dr. Diamond. “These are the first drugs you should try.”
“If the patient has a sleep disorder, we at the Diamond Headache Clinic use amitriptyline,” he said. “If sleep disorder is not listed as a co-morbidity, we use a non-sedating tricyclic antidepressant.
Monamine oxidase inhibitors (MAOIs) such as the hydrazine derivatives pheneizine and isocarboxazid are very effective in the treatment of the chronic daily headache, continued Dr. Diamond.
“We use them at the Diamond Clinic, but you should not,” he cautioned.
“As you all know, MAOIs have side effects such as postural hypotension and weight gain, and dangerous interactions with many classes of drugs, including antihypertensives, decongestants, appetite suppressants, L-Dopa, and amphetamines,” warned Dr. Diamond. He pointed out that all drugs have side effects and that patients should be warned about those side effects and possible drug interactions. For instance, with the tricyclics antidepressants, patients often get dry mouth, constipation, and blurred vision.
“Doctors should treat side effects before they occur by explaining to the patients, for example, that they may get tingling sensations in their hands, but not to worry because this may disappear after a couple of days,” Dr. Diamond explained later in an interview.
In closing, he stated the most important thing doctors can do for their headache patients is to “give them continuity of care.” The headache patient cannot be treated on a one-shot basis, he said. “You have to be able to follow up and see how they are doing.”
Copyright 2008 Elsevier Custom Conference Coverage. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the copyright owner. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made. Opinions expressed in this publication are those of the original authors and do not necessarily reflect those of the Publisher, the sponsor, or the editors. Elsevier assumes no liability for any material published herein.
 

Terms of Use                                    Privacy Policy                                    Contact Us

 
  Copyright ©2010 Elsevier/International Medical News Group
  5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Rights reserved Clinical Neurology News Network